Mannkind (MNKD) Treasury Shares (2011 - 2026)
Mannkind (MNKD) reported Treasury Shares of $18.1 million for Q1 2026, up 9.63% quarter-over-quarter from $16.5 million in Q4 2025.
Mannkind (MNKD) Treasury Shares (2011 - 2026) Analysis & Trends
Mannkind (MNKD) has 16 years of Treasury Shares data on file, last reported at $18.1 million in Q1 2026.
- Treasury Shares for Q1 2026 came in at $18.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $18.1 million (changed N/A YoY), and the FY2025 annual result was $16.5 million, up 16.68% from the prior year.
- Treasury Shares climbed to $18.1 million in Q1 2026 per MNKD's latest filing, from $16.5 million in the prior quarter.
- Over five years, Treasury Shares peaked at $18.1 million in Q1 2026 and troughed at $11.8 million in Q4 2022.
- A 5-year average of $14.6 million and a median of $14.1 million in 2024 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2023: Treasury Shares climbed 24.12% in 2022, then advanced 4.44% in 2023.
- A 5-year view of Treasury Shares shows it stood at $11.8 million in 2022, then climbed by 4.44% to $12.4 million in 2023, then grew by 14.28% to $14.1 million in 2024, then advanced by 16.68% to $16.5 million in 2025, then rose by 9.63% to $18.1 million in 2026.
- Business Quant data shows MNKD's Treasury Shares at $18.1 million in Q1 2026, $16.5 million in Q4 2025, and $14.1 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 18.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.07 Mn |
| Mar 31, 2026 | 18.07 Mn |
| Dec 31, 2025 | 16.49 Mn |
| Dec 31, 2025 | 16.49 Mn |
| Dec 31, 2024 | 14.13 Mn |
| Dec 31, 2024 | 14.13 Mn |
| Dec 31, 2023 | 12.36 Mn |
| Dec 31, 2023 | 12.36 Mn |
| Dec 31, 2022 | 11.84 Mn |
| Dec 31, 2022 | 11.84 Mn |
| Dec 31, 2021 | 9.54 Mn |
| Dec 31, 2021 | 9.54 Mn |
| Dec 31, 2020 | 6.04 Mn |
| Dec 31, 2020 | 6.04 Mn |
| Dec 31, 2019 | 1.06 Mn |
| Dec 31, 2019 | 1.06 Mn |
| Dec 31, 2018 | 691,266.00 |
| Dec 31, 2018 | 691,266.00 |
| Dec 31, 2017 | 1.14 Mn |
| Dec 31, 2017 | 1.14 Mn |